Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Clinical healthcare researchers, academic and industry experts from eight countries collaborate to advance the goal of identifying the right drug dose for each patient
The briefing paper explores the regulatory framework and the setting up of the Committee for Orphan Medicinal Products, and raises awareness around the latest developments in this field
Industry research, referrals and consultants remain the top drivers of CRO and CDMO selection, but trade shows are a good way to learn about outsourcing firms and whether their capabilities fit your needs, writes Wei Gao, Director of Accounts, That’s Nice LLC/Nice Insight
New paper explains how TSPO levels can help to provide a real-time picture of inflammation related to neurodegenerative diseases
Project will allow both companies to provide efficient immobilised catalysts for the mild and selective oxidation of chemical intermediates and APIs
Zika may not be a new virus but its newly confirmed ability to cause foetal brain abnormalities makes the search for a treatment or a vaccine a high priority. Dr Sarah Houlton looks at the latest initiatives
Albumedix albumin-based half-life extension technology used in clinical development of Changshan’s once-weekly diabetes treatment for the Chinese market
The growth of biologics has been rapid and new generation therapies are now using multiple therapies within doses. Catalent looks at some of the pioneering technologies available to help to achieve more consistent manufacture of multiple recombinant proteins and better ADCs
The UK’s Cell and Gene Therapy Catapult and the Australian CRC for Cell Therapy Manufacturing will collaborate to advance scaffold technology for the commercial production of T-cells
Contract development and manufacturing organisations can help optimise time to market as well as bringing technical expertise and high quality manufacturing services to the development of innovative technologies for solid dose delivery, argues Recipharm
The drug tablet has three components, including a polymer containing the drug in a specifically designed shape that will determine the rate of release
Dr Cynthia A. Challener, Scientific Content Editor, Nice Insight, compares the benefits of various catalytic technologies and concludes that the outright winner is the patient